Cognitive functioning in ultra-high risk for psychosis individuals with and without depression: Secondary analysis of findings from the NEURAPRO randomized clinical trial.
Mallawaarachchi SR, Amminger GP, Farhall J, Bolt LK, Nelson B, Yuen HP, McGorry PD, Markulev C, Schäfer MR, Mossaheb N, Schlögelhofer M, Smesny S, Hickie IB, Berger GE, Chen EYH, de Haan L, Nieman DH, Nordentoft M, Riecher-Rössler A, Verma S, Thompson A, Yung AR, Allott KA.
Mallawaarachchi SR, et al.
Schizophr Res. 2020 Apr;218:48-54. doi: 10.1016/j.schres.2020.03.008. Epub 2020 Mar 11.
Schizophr Res. 2020.
PMID: 32171637
Clinical Trial.